The Genomic Biomarker market size is expected to reach $22.23 billion in 2030 at a CAGR of 17.5%, driven by increasing prevalence of chronic diseases.
Read More
The Genome Sequencing market size is expected to reach $28.07 billion in 2030 at a CAGR of 18.9%, driven by increasing occurrence of cancer.
Read More
The Genitourinary Drugs market size is expected to reach $35.69 billion in 2030 at a CAGR of 2.8%, driven by growing prevalence of genitourinary disorders.
Read More
The Genetic Mutation Analysis market size is expected to reach $11.47 billion in 2030 at a CAGR of 11.5%, driven by rising prevalence of genetic disorders.
Read More
The Genetic Analysis market size is expected to reach $18.75 billion in 2030 at a CAGR of 12.7%, driven by increasing cases of cancer.
Read More
The Generic Pharmaceuticals Contract Manufacturing market size is expected to reach $93.56 billion in 2030 at a CAGR of 6.9%, driven by rising demand for biosimilars.
Read More
The Generic Pharmaceuticals market size is expected to reach $588.24 billion in 2030 at a CAGR of 6.7%, driven by increasing incidence of chronic diseases.
Read More
The Generic Oncology Drugs market size is expected to reach $39.99 billion in 2030 at a CAGR of 7.0%, driven by significant rise in cancer patients.
Read More
The Generic Musculoskeletal Disorders Drugs market size is expected to reach $0.09 billion in 2030 at a CAGR of 6.9%, driven by increasing adoption of telemedicine.
Read More
The Generic Injectables market size is expected to reach $267.93 billion in 2030 at a CAGR of 13.7%, driven by rising prevalence of cancer and cardiovascular diseases.
Read More